Zirabev (bevacizumab-bvzr) / Pfizer  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zirabev (bevacizumab-bvzr) / Pfizer
NCT02031991: A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01)

Completed
1
102
US
PF-06439535, PF-06439535, a potential biosimilar to bevacizumab, Avastin, Bevacizumab (European Union), Bevacizumab (United States)
Pfizer
Healthy
08/14
08/14
NCT04126044: A SINGLE-DOSE, 2-ARM, PHARMACOKINETIC STUDY OF PF-06439535 (CN) AND EUROPEAN UNION SOURCED BEVACIZUMAB IN CHINESE HEALTHY MALE VOLUNTEERS

Withdrawn
1
0
RoW
PF-06439535 (CN), bevacizumab - EU
Pfizer
Pharmacokinetics
07/21
07/21

Download Options